Mashayekhian, M. and Hassanian-Moghaddam, H. and Rahimi, M. and Zamani, N. and Aghabiklooei, A. and Shadnia, S. (2016) Elevated Carboxyhaemoglobin Concentrations by Pulse CO-Oximetry is Associated with Severe Aluminium Phosphide Poisoning. Basic and Clinical Pharmacology and Toxicology, 119 (3). pp. 322-329.
Full text not available from this repository.Abstract
In pulse CO-oximetry of aluminium phosphide (ALP)-poisoned patients, we discovered that carboxyhaemoglobin (CO-Hb) level was elevated. We aimed to determine whether a higher CO level was detected in patients with severe ALP poisoning and if this could be used as a prognostic factor in these patients. In a prospective case�control study, 96 suspected cases of ALP poisoning were evaluated. In the ALP-poisoned group, demographic characteristics, gastric and exhalation silver nitrate test results, average CO-Hb saturation, methaemoglobin saturation, and blood pressure and blood gas analysis until death/discharge were recorded. Severely poisoned patients were defined as those with systolic blood pressure �80 mmHg, pH �7.2, or HCO3 �15 meq/L or those who died, while patients with minor poisoning were those without any of these signs/symptoms. A control group (37 patients) was taken from other medically ill patients to detect probable effects of hypotension and metabolic acidosis on CO-Hb and methaemoglobin saturations. Of 96 patients, 27 died and 37 fulfilled the criteria for severe poisoning. All patients with carbon monoxide saturation >18 met the criteria to be included in the severe poisoning group and all with a SpCO >25 died. Concerning all significant variables in univariate analysis of severe ALP toxicity, the only significant variable which could independently predict death was carbon monoxide saturation. Due to high mortality rate and need for intensive care support, early prediction of outcome is vital for choosing an appropriate setting (ICU or ordinary ward). CO-oximetry is a good diagnostic and prognostic factor in patients with ALP poisoning even before any clinical evidence of toxicity will develop. © 2016 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society)
| Item Type: | Article |
|---|---|
| Additional Information: | cited By 7 |
| Depositing User: | eprints admin |
| Date Deposited: | 07 Jul 2018 08:49 |
| Last Modified: | 07 Jul 2018 08:49 |
| URI: | http://eprints.iums.ac.ir/id/eprint/3316 |
Actions (login required)
 |
View Item |
